Oral Cancer Biopsy: How It Is Done, What the Pathology Report Means & What Happens Next

Being told that you need a biopsy of a suspicious area inside your mouth is one of the most anxiety-producing moments a patient can face. The questions arrive all at once: Is it cancer? What will the biopsy involve? Will the results change my life?

Knowing exactly what happens during an oral cancer biopsy, how to read the pathology report that follows, and what the results mean for your treatment plan makes the wait easier and the decisions clearer.

This guide covers when a mouth lesion needs a biopsy, what the procedure involves step by step, what the terms on your pathology report mean, and what happens next. It reflects how Dr. Pradeep S. and Dr. Kalpa Pandya explain these results to patients at Mouth Cancer Surgeons in Chennai.

---

When Does a Mouth Lesion Need a Biopsy?

Not every mouth sore or spot requires a biopsy. Most oral ulcers are benign aphthous ulcers (canker sores), traumatic bites, or irritation from sharp teeth. However, specific clinical features should raise concern and trigger urgent specialist evaluation.

The Two-Week Rule

A fundamental guideline in oral medicine states: any oral ulcer, persistent white or red patch, or tissue growth that has not started healing within 14 days, even after obvious local irritants such as sharp teeth or ill-fitting dentures have been removed, must be biopsied.

This is because the most common oral precancers and cancers can closely mimic benign conditions in their early stages. The only way to definitively distinguish between them is microscopic examination of the tissue.

Clinical Signs That Demand Urgent Biopsy

• Non-healing ulcer: An ulcer lasting more than two weeks, especially one with raised, hardened (indurated) borders. Learn how to distinguish dangerous ulcers from harmless ones in our guide on warning signs of a malignant mouth ulcer.

• Persistent white patches (Leukoplakia): A white patch that cannot be rubbed off. Leukoplakia has a malignant transformation rate of approximately 3% to 17%, depending on the clinical subtype.

• Red patches (Erythroplakia): A smooth, velvety red patch on the oral mucosa. Erythroplakia carries the highest risk of malignant transformation among all oral potentially malignant disorders (OPMDs), at over 30%.

• Mixed red-and-white patches (Erythroleukoplakia): These carry a very high suspicion for early invasive carcinoma.

• Indurated (hardened) lump or mass: A firm, non-tender nodule in the tongue, cheek, gum, or floor of mouth that feels anchored to deeper tissues. For guidance on evaluating oral lumps, read our article on mouth lumps: benign vs malignant.

• Exophytic growth: A cauliflower-like mass growing outward from the mucosal surface.

• Progressive difficulty opening the mouth (Trismus): In patients with a history of smokeless tobacco use, this may indicate oral submucous fibrosis (OSMF) that requires biopsy to assess for dysplasia or early malignant change.

• Neck lymphadenopathy: A firm, painless lump in the neck accompanying any oral lesion suggests possible metastasis and warrants an immediate biopsy of the oral lesion.

---

What Happens During an Oral Cancer Biopsy: Step by Step

A tissue biopsy is a minor, outpatient procedure typically completed within 15 to 20 minutes. Most patients find it far less daunting than expected once they know each step.

Step 1: Clinical Examination

Before performing the biopsy, your surgeon will conduct a thorough examination of the entire oral cavity under high-intensity light, palpating (feeling) the lesion and surrounding tissues to assess its consistency, depth, and relationship to adjacent structures. The neck will also be examined for enlarged lymph nodes. This is the same examination used in a routine oral cancer screening.

Step 2: Numbing the Area (Local Anaesthesia)

A topical anaesthetic gel is first applied to the lesion area to numb the surface. Then, a small injection of local anaesthetic (typically 2% lidocaine with 1:100,000 epinephrine) is administered around the lesion. This completely numbs the site. Patients typically feel a brief, mild pinch from the needle and then no further sensation during the procedure.

Step 3: Tissue Sampling

The surgeon selects the most appropriate biopsy technique based on the clinical situation:

• Incisional Biopsy: The most common type for suspected oral cancers. A small, representative wedge of tissue (typically 5–8 mm) is removed from the edge of the lesion, capturing both abnormal tissue and a small border of adjacent healthy-looking tissue. This allows the pathologist to examine the transition zone. An incisional biopsy does not attempt to remove the entire lesion. Its purpose is a diagnostic sample.

• Excisional Biopsy: The entire lesion is removed in one piece with a small margin of healthy tissue. This is appropriate only for small, well-defined, superficial lesions (typically less than 1.5 cm) where the clinical suspicion for invasive cancer is low. If the pathology subsequently reveals cancer, further surgery may still be needed to achieve wider margins.

• Punch Biopsy: A specialised cylindrical blade (4–6 mm diameter) is used to take a core of tissue. Useful for flat lesions such as leukoplakia or erythroplakia.

Step 4: Stopping Any Bleeding (Haemostasis)

The tongue, cheek, and floor of the mouth have a rich blood supply. After the tissue sample is taken, the surgeon controls bleeding using one or two dissolvable sutures, gentle electrocautery, or direct pressure.

Step 5: Specimen Preservation and Submission

The tissue sample is immediately placed in a container of 10% neutral buffered formalin (a preservative solution) and sent to an oral pathologist or histopathologist for processing and microscopic analysis. The specimen is labelled with the patient's details, the site of the biopsy, and any relevant clinical information.

Important: Bringing Outside Biopsy Materials

If you have already had a biopsy performed at another hospital or clinic and are seeking a second opinion or treatment at our centre, we strongly recommend bringing:

• The complete pathology report (not just a summary).
• The original biopsy slides (glass slides with tissue sections) and/or the paraffin block (the preserved tissue sample embedded in wax).

This allows our pathology team to review the original tissue directly, ensuring diagnostic accuracy before we plan treatment. This step can save you from needing a repeat biopsy.

---

Post-Biopsy Recovery: What to Expect

Recovery from an oral biopsy is generally quick and straightforward.

The First 48 Hours

• Mild soreness at the biopsy site, easily managed with standard oral pain medications (paracetamol or ibuprofen as prescribed).
• Minor oozing or spotting of blood from the site, which usually stops within a few hours. Avoid spitting, using straws, or rinsing vigorously for the first 12 hours.
• Eat soft, lukewarm foods: yoghurt, smoothies, mashed dal and rice, porridge, lukewarm soups. Avoid hot, spicy, crunchy, or acidic foods.

Days 2 to 7

• Begin gentle warm saline rinses (half a teaspoon of salt in a glass of warm water) 2–3 times daily to keep the biopsy site clean.
• Avoid alcohol-based mouthwashes, smoking, and chewing tobacco.
• The biopsy site typically heals completely within 7 to 10 days.

When to Contact Your Surgeon

Contact us immediately if you experience:

• Continuous, heavy bleeding that does not stop with 20 minutes of firm gauze pressure.
• Increasing swelling, redness, or warmth at the biopsy site.
• Fever above 101°F (38.3°C).
• Foul-smelling discharge from the wound.

---

Understanding Your Pathology Report: What the Results Mean

The pathology report is the single most important document in your oral cancer care. It contains the definitive diagnosis and the microscopic details that directly determine your treatment plan.

Many patients receive their report and feel confused by the medical terminology. This section explains the key terms in plain language.

Possible Diagnoses

1. Benign (Non-Cancerous)

The tissue shows no evidence of dysplasia or malignancy. Examples include fibrous hyperplasia, pyogenic granuloma, or mucocele. No cancer treatment is needed, although the underlying cause (chronic irritation, sharp tooth) should be addressed.

2. Dysplasia (Precancerous Change)

The cells show abnormal changes but have not invaded through the basement membrane. Dysplasia is graded as:

• Mild Dysplasia: Abnormal changes confined to the lower third of the epithelium. Low risk of progression. Usually monitored with regular clinical follow-up.
• Moderate Dysplasia: Abnormal changes extending into the middle third. Intermediate risk. May require excision and close surveillance.
• Severe Dysplasia / Carcinoma In Situ (CIS): Abnormal changes through the full thickness of the epithelium, but the basement membrane remains intact. High risk of progressing to invasive cancer. Surgical excision with clear margins is strongly recommended.

Understanding dysplasia is important because it is a window in which the condition can be treated before it becomes invasive cancer.

3. Squamous Cell Carcinoma (SCC)

This is the diagnosis of cancer. It means that abnormal squamous cells have broken through the basement membrane and invaded the underlying connective tissue and muscles. Oral squamous cell carcinoma accounts for approximately 90% of all oral cancers.

Key Terms on Your Cancer Pathology Report

Once a diagnosis of SCC is confirmed, the report will include several additional details that are critical for treatment planning:

Histological Grade (Differentiation)

This describes how closely the cancer cells resemble normal, healthy squamous cells:

Surgical Margins

If the biopsy was excisional (attempted to remove the entire lesion), the report will comment on margins:

• Clear (Negative) Margins: No cancer cells are seen at the cut edges. The tumour was completely removed with a rim of healthy tissue.
• Close Margins: Cancer cells are present within 5 mm of the cut edge. This raises concern for residual microscopic disease and may necessitate re-excision or adjuvant radiation.
• Positive Margins: Cancer cells are present at the very edge of the specimen. This means cancer was likely left behind, and further surgery or radiation is required.

Depth of Invasion (DOI)

How deep the cancer has penetrated below the surface basement membrane. This is one of the most important prognostic factors in the AJCC 8th edition staging system:

• DOI ≤ 5 mm: Generally corresponds to T1 disease (small, superficial).
• DOI 5–10 mm: May upstage the tumour to T2 regardless of surface size.
• DOI > 10 mm: Indicates T3 disease with a high risk of lymph node spread.

A DOI greater than 4 mm is the threshold at which an elective neck dissection is strongly recommended, even if imaging shows no evidence of lymph node involvement. For how the operation is planned and performed, see our neck dissection procedure page.

Perineural Invasion (PNI)

This means cancer cells have been found growing along or around the nerve fibres within the tissue. PNI is a high-risk feature associated with:

• Increased risk of local recurrence.
• Pain and nerve-related symptoms (numbness, tingling).
• A strong indication for post-operative radiation therapy.

Lymphovascular Invasion (LVI)

This means cancer cells have entered the small blood vessels or lymphatic channels within the tissue. LVI is a significant finding because it indicates that the cancer has gained access to the body's transportation network, increasing the risk of regional lymph node metastasis and distant spread.

---

What Happens After a Biopsy Confirms Cancer: The Next Steps

A cancer diagnosis on a biopsy report is distressing. What follows, though, is a well-defined sequence of steps, and knowing them in advance helps.

Step 1: Staging, or Mapping the Full Extent of Disease

Once cancer is confirmed, the next priority is determining how far the cancer has spread. This is called staging and involves advanced imaging:

• Contrast-Enhanced CT (CECT): Detailed cross-sectional images of the oral cavity, jaw, and neck to assess tumour extent and lymph node status.
• MRI: Superior soft-tissue contrast for evaluating the depth and borders of the primary tumour, especially in the tongue and floor of mouth.
• PET-CT: Used in advanced cases to scan the entire body for distant metastasis (lungs, liver, bones).

For a complete explanation of how staging works, read our guide on oral cancer stages explained.

Step 2: Multidisciplinary Tumour Board Review

At Apollo Main Hospital, your case is presented to a multidisciplinary tumour board, a panel of surgical oncologists, radiation oncologists, medical oncologists, pathologists, and radiologists. Together, they review your biopsy report and imaging to create an individualised treatment plan.

Step 3: Treatment Planning

Based on the stage, location, and pathological features of the cancer, the treatment plan typically involves:

• Surgical resection of the primary tumour with adequate margins.
• Neck dissection, either therapeutic (if nodes are involved) or elective (if DOI exceeds 4 mm).
• Reconstructive surgery, if the resection creates a significant tissue defect. Learn about reconstruction options on our oral reconstruction page.
• Adjuvant radiation or chemoradiation, if high-risk pathological features are present.

Step 4: Pre-Operative Preparation

Before surgery, you will undergo medical clearance (cardiac, pulmonary, anaesthetic), nutritional optimisation, and tobacco/alcohol cessation counselling. If you currently use tobacco in any form, stopping now matters for wound healing and for your long-term risk. Our guide on quitting tobacco after an OPMD diagnosis explains how.

For an overview of treatment options, including surgery, radiation, and chemotherapy, see our oral cancer treatment guide. Early lesions may be managed with wide local excision; the broader specialty pathway is summarised under oral cancer care.

---

From Suspicion to Treatment Plan: A Typical Timeline

The path from a suspicious lesion to a confirmed, staged diagnosis has a predictable shape. This is what it usually looks like:

From biopsy to surgery, the whole process should take no more than 4 to 6 weeks. Delays at any step give the cancer time to grow, which can mean more extensive surgery and a worse outcome.

---

Getting a Biopsy or a Second Opinion in Chennai

At Mouth Cancer Surgeons, the surgeon who performs your biopsy is the same surgeon who reviews the pathology, plans the operation, and follows you up afterwards. Two surgeons share every case.

• Dr. Pradeep S. (MDS, FHNO, FIBCSOMS) is a head and neck surgical oncologist with international board certification. He performs diagnostic biopsies, cancer resections, neck dissections, and microvascular reconstruction.

• Dr. Kalpa Pandya (MDS, FHNS) has treated more than 1,000 oral cancer patients over ten years, with a particular focus on oral potentially malignant disorders, dental rehabilitation after treatment, and follow-up care.

Both surgeons practise at Apollo Main Hospital, Greams Road, Chennai, which has in-house pathology, imaging, and a full oncology team, so biopsy, reporting, staging, and surgery happen in one place without handoffs.

If you have a suspicious mouth lesion, an unresolved oral biopsy report from another centre, or a confirmed diagnosis requiring treatment planning, book an appointment with Dr. Pradeep S. and Dr. Kalpa Pandya, or meet the team on our doctors page.

References

1. Warnakulasuriya, Saman, et al. "Oral Potentially Malignant Disorders: A Consensus Report from an International Seminar on Nomenclature and Classification." Oral Diseases, 2021.

2. National Comprehensive Cancer Network (NCCN). "Clinical Practice Guidelines in Oncology: Head and Neck Cancers." NCCN Guidelines, 2025. [https://www.nccn.org]

3. American Joint Committee on Cancer (AJCC). "AJCC Cancer Staging Manual, 8th Edition: Oral Cavity." Springer, 2017.

4. World Health Organization (WHO). "Classification of Head and Neck Tumours." WHO Classification of Tumours, 5th Edition, 2022.

5. Speight, P. M. "Update on Oral Epithelial Dysplasia and Progression to Cancer." Head and Neck Pathology, 2007.

6. National Cancer Institute (NCI). "Lip and Oral Cavity Cancer Treatment (PDQ), Patient Version." NCI, 2024. [https://www.cancer.gov]